BIOCHEMICAL SOCIETY TRANSACTIONS that growth on phenylacetamide could not be attributed to any residual activity of the aliphatic amidase. It seemed clear that the wild type P. putida A87 is capable of producing two separate amidases and carries genes for the structure and regulation of both an aliphatic amidase and an aromatic amidase. Similar conclusions were reached for P . cepacia strain 716.
Chloramphenicol has served as focal point for a wide range of biomedical studies over more than two decades since its introduction as the prototype 'broad-spectrum' antibiotic. Although its clinical applications are now limited by reason of its potential toxicity, there is a large body of data chronicling the early 'emergence' of bacterial resistance to chloramphenicol and, more recently, confirming the view that most examples of the resistance phenotype in clinically important bacteria are due to an extra-chromosomal gene for an inactivating enzyme (Shaw, 1967; 1971~) . The enzyme in question, chloramphenicol acetyltransferase, catalyses the U-acetylation of chloramphenicol by using acetyl-CoA as the acyl donor. The mono-and di-acetoxy derivatives of chloramphenicol fail to bind to bacterial ribosomes and have virtually no anti-bacterial activity (Shaw & Unowsky, 1968) . When chloramphenicol-resistant bacteria which harbour the chloramphenicol acetyltransferase gene are inoculated into media containing chloramphenicol they remain in a stationary growth phase until the concentration of free antibiotic falls to a value which is no longer inhibitory, at which point exponential growth ensues with the same division time shown by control cultures. The physiological 'story' of plasmidmediated chloramphenicol resistance would therefore be quite straightforward were it not for a complication which pointed to fundamental genetic differences between genera of bacteria containing chloramphenicol acetyltransferase.
Chloramphenicol-resistant staphylococci (and certain other bacteria described in Table 1 ) synthesize chloramphenicol acetyltransferase only when exposed to the parent antibiotic or certain of its analogues, whereas Escherichia coli and other members of the enteric flora which frequently harbour plasmids (R factors) for chloramphenicol resistance are constitutive producers of chloramphenicol acetyltransferase. The paradox of chloramphenicol, the model inhibitor of induced enzyme synthesis in bacteria, serving as the inducer (or co-repressor) of chlorarnphenicol acetyltransferase synthesis, is The biologically active natural product has the asymmetric carbon atoms at positions C-1 and C-2 in the D, threo configuration and has the following substituents: R1 = -NOz, Rz = -COCHC12 and R3 = -OH. Compounds lacking an acyl group at Rz are not substrates, nor are analogues in which the propane-1,3-diol structure is disturbed. The 'gratuitous' inducer of chloramphenicol acetyltransferase (R3 = -H) is neither a substrate nor an inhibitor of protein synthesis.
amusing, but the kinetics of enzyme synthesis observed under such conditions are complex. The concentration of chloramphenicol must be high enough to induce but low enough to permit chloramphenicol acetyltransferase synthesis, after which chloramphenicol is acetylated and enzyme synthesis ceases for lack of effective inducer (Shaw & Brodsky, 1968) . This annoying complication can be obviated by induction under 'gratuitous' conditions with an analogue of chloramphenicol which is neither a substrate for chloramphenicol acetyltransferase nor an effective inhibitor of protein synthesis (Winshell & Shaw, 1969) . Such a compound is 3-deoxy chloramphenicol (where RI = H rather than -OH, see Fig. 1 ). Although only a few species of bacteria have been studied in the same detail as the staphylococci, it is now clear that all of the inducible chloramphenicol transferase systems described in Table 1 respond to the gratuitous inducer as well as the parent antibiotic. Thus, although the host bacteria show gross differences in morphology, metabolism and DNA base-composition, and the chloramphenicol transferase proteins show quite divergent properties (see below), the plasmids (proven or presumed) must contain homologous genes specifying the recognition protein(s) required for either positive or negative control. By inference the R-factor-mediated (enteric) chloramphenicol resistance gene(s) would consist of either (a) the chloramphenicol acetyltransferase structural gene alone or (b) the chloramphenicol acetyltransferase gene plus the DNA template for the synthesis of a regulatory
VOl. 2 protein which no longer requires chloramphenicol for activity. On apriori grounds the genetic stability of the latter element in a model for the constitutive synthesis of R factor chloramphenicol acetyltransferase seems unlikely. One must account for the observation that no naturally occurring R+ strains of enteric bacteria inducible for chloramphenicol acetyltransferase have been found and also for the inability to isolate revertants of the putative 'mutant' regulatory gene in model (b).
The obvious route to an understanding of the induction of chloramphenicol acetyltransferase in staphylococci would be the isolation of plasmid mutants constitutive for chloramphenicol acetyltransferase and a study of their effect (trans to the gene for an inducible) chloramphenicol acetyltransferase of different type. This approach has proved useful in understanding the genetics of penicillinase synthesis in Staphylococcus aureus (Richmond, 1967) and the enzymic tools are not wanting for the chloramphenicol acetyltransferase system (Shaw et al., 1972; Sands & Shaw, 1973) . The problem has been that, unlike the penicillinase plasmids which replicate at a low multiplicity in S. aureus, the chloramphenicol plasmid appears to be present in many copies per chromosome (R. Novick, personal communication). The observation that constitutive chloramphenicol acetyltransferase mutants cannot be isolated directly from such inducible parents must be related to the multiplicity of regulatory gene copies. The most promising way out of this dilemma appears to be the technique of 'transfection', utilizing a S. aureus chloramphenicol plasmid as the source of chloramphenicol acetyltransferase template DNA for the transformation of E. coli spheroplasts. Cohen and his collaborators (Cohen et al., 1973) have demonstrated the feasibility of the method for R-factor drug-resistance genes and have extended it recently to the construction of novel plasmids in general. Restriction endonucleases have been employed to develop specific and identical cleavage sites in donor and recipient plasmid DNA followed by formation of the desired novel plasmid by DNA ligase (Cohen et al., 1973) . We are undertaking such studiesnot only to examine the genetic basis of chloramphenicol acetyltransferase inducibility by substrate but also to examine the response of S. aureus chloramphenicol acetyltransferase gene to the cyclic AMP-dependent E. colicatabolite-repression systemwhich is so effective as a modulator of chloramphenicol transferase synthesis in viable cells and in vitro (Harwood & Smith, 1971; de Crombrugge et al., 1973) .
Whereas a genetic approach appeared necessary at the outset to understand the control of chloramphenicol acetyltransferase synthesis and bacterial physiology of chloramphenicol resistance, it is now apparent that genetic tools will also be essential to an understanding of chloramphenicol acetyltransferase function and perhaps of its evolution. The diversity of microbial species containing chloramphenicol acetyltransferase is striking, but even more dramatic is the finding that, at least in clinically important species such as E. coli and S. aureus, the enzyme cannot be detected in chloramphenicol-sensitive (plasmid-negative) strains, nor do such isolates yield chloramphenicol acetyltransferase after mutagenesis and selection for resistance. A likely explanation is that there is no chromosomal chloramphenicol acetyltransferase gene ('silent' or otherwise) which can be 'rescued' to effect chloramphenicol resistance by this mechanism. Such is not the case in many Gram-negative isolates classified as Proteus or Providencia species. Most, but not all, contain very low levels of chloramphenicol acetyltransferase activity and are chloramphenicol-sensitive. Those strains which do contain this activity readily yield single-step resistant mutants with a chloramphenicol acetyltransferase specific activity (in cell extracts) which approaches that of conventional R+ (E. coli) strains, whereas those wild-type strains which do not contain detectable chloramphenicol acetyltransferase fail to provide chloramphenicol-resistant mutants when treated under similar conditions. Strains of wild-type (sensitive) Proteus mirabilis which have been chloramphenicol acetyltransferase-positive before selection have been found to contain amounts of a protein which cross-reacts with antibody prepared against the chloramphenicol acetyltransferase from resistant mutants. Further, when studied by quantitative immunodiffusion, the amount of this low-activity chloramphenicol acetyltransferase is comparable with that found in fully resistant derivative strains. In several such independent pairs of strains which are isogenic save for the determinants of chloramphenicol acetyltransferase activity, the apparent K , values for chloramphenicol have been 20-40-fold lower for the enzyme from the resistant mutant (Shaw, 19716) . By way of contrast, one chloramphenicol-resistant isolate picked at random has yielded increased amounts of the chloramphenicol acetyltransferase protein with the same K , as that observed for the enzyme from the sensitive parent (L. Sands & W. Shaw, unpublished work) . Thus, two types of response have been observed in the transition from sensitive to resistant phenotype, a variant of the original enzyme on the one hand and increased synthesis of the parental chloramphenicol acetyltransferase on the other. The alternative responses possible are obviously reflections of the choices available to any gene under selection pressure. Hartley and his collaborators have recently described this phenomenon in more detail in the ribitol dehydrogenase system of Klebsiella aerogenes when selection is made for growth on xylitol rather than ribitol (Hartley, 1974) .
It may be argued that the ubiquity of chloramphenicol acetyltransferase-positive strains of Proteus and Providencia is simply a reflection of a high integration potential for the R-factor chloramphenicol acetyltransferase gene for these species rather than having to invoke our explanation that the episomal chloramphenicol acetyltransferase gene has evolved from an ancestral (chromosomal) transacetylase in Proteus or Providencia species. Although a corresponding degree of caution is also warranted in interpreting future comparisons of chloramphenicol acetyltransferase from Streptomyces species (Table 1) with the plasmid-related enzymes, there are some grounds for suspecting a more central role for chloramphenicol acetyltransferase in such microbial species which are antibiotic producers (Benveniste & Davies, 1973) . A case in point is the streptomycinphosphorylating enzyme from Streptomyces griseus, the function of which is not clear but which bears striking similarities with that which is an effector of R-factor-mediated resistance to streptomycin (Walker & Skorvaga, 1973) .
Apart from considerations of the evolution and control of a rather novel episomal enzyme, the study of the more accessible types of chloramphenicol acetyltransferase in E. coli and S. aureus promises insights into the structure and function of a protein with interesting properties in its own right. Native chloramphenicol acetyltransferase has a tetrameric structure consisting of subunits of 20000 mol.wt. Irrespective of source, chloramphenicol acetyltransferase recognizes only one of the four possible diastereoisomers of chloramphenicol (D, threo; see Fig. l) , that which is active as an antibiotic because of its specific inhibition of polypeptide elongation. The central role of chloramphenicol acetyltransferase in the chloramphenicol-resistance phenotype of the host bacterium simplifies selection for alterations in enzyme function, a principle which has led to the isolation of a number of mutants which are proving useful for structurefunction correlations. The best characterized are those of Foster & Howe (1971) whose study demonstrated complementation in uivo between the structural gene products from two different chloramphenicol acetyltransferase point mutants derived from the same R factor. Their use of such a dual plasmid strain of E. coliconfirmed the identity of subunits for any given chloramphenicol acetyltransferase gene, an observation which was independently shown for the S. aureus enzymes by conventional techniques of protein chemistry (Shaw et al., 1970 ). The point mutants described above included several which gave cross-reacting material with anti-chloramphenicol acetyltransferase immune sera and had low but measurable enzyme activity and also a number which had neither property (Foster & Howe, 1973) . Three of the latter do not appear to be defective owing to premature chain termination, since they are not suppressed by a variety of well characterized Su+ hosts (R. Hedges & W. Shaw, unpublished work), and may therefore include mis-sense mutants which could be useful in correlating the tertiary structure of chloramphenicol acetyltransferase with its catalytic properties. To this end (and also to simplify the characterization of the chloramphenicol acetyltransferase 'family' of enzymes) the primary structure of one of the three naturally occurring R-factor variants of chloramphenicol acetyltransferase has been determined (W. Shaw, B. D. Burleigh, A. Dell, B. Hartley & H. Morris, unpublished work). Attempts are now under way to obtain crystals suitable for X-ray-diffraction studies.
One of the most interesting observations to emerge from studies of chloramphenicol acetyltransferase as a protein has been the anomalous hybridization behaviour of its subunits. Representatives of the major 'families' of plasmid-linked chloramphenicol acetyltransferase can be most easily discerned on the basis of their reaction with specific immune sera and also by their ability to undergo reversible denaturation to form active heteromeric enzyme when the parental chloramphenicol acetyltransferase species in each pair are both derived from S. aureus on the one hand or are R-factor gene products on the other (Sands & Shaw, 1973; Shaw et al., 1972) . From the firm knowledge that any given type of chloramphenicol acetyltransferase is composed of four identical monomers such 'species-specific' hybridization experiments in vitro between polypeptides A and B might have been expected to yield five possible tetrameric variants, namely A4, A3B, AzBz, AB3 and B4. The results of such experiments showed that both the S. aureus heteromers and their R factor (E. coli) counterparts were solely of the A2B2 type. The absence of the expected asymmetrical forms (A3B and AB,) was confirmed in E. coli by hybridization in uivo (Shaw et al., 1972) by using the dual plasmid approach of Foster & Howe (1971) which had proved successful in demonstrating complementation. The simplest hypothesis to explain the discrimination against the missing hybrids is that (a) formation of the active tetramer must proceed via the association of dimers, (6) the surface interactions between monomers for dimer formation are specific and therefore critical, and (c) the dimer-dimer (AA-BB) association must be less dependent on the precise topography of their interface. Whileno data are available to confirmor alter this view, it is of interest that a hybrid chloramphenicol acetyltransferase detected by complementation in uiuo (Foster & Howe, 1972) was quite labile, suggesting that a careful study of the reassociation kinetics for both wild-type and complementing mutants of chloramphenicol acetyltransferase might be rewarding.
